Jane Doe, M.D., Ph.D.
CURRICULUM VITAE SAMPLE
Date of Revision:
Name: Jane Doe, M.D., Ph.D.
Proposed for Promotion to: Associate Professor with Tenure, Department of Pathology Traditional Track, with a Secondary Appointment in the Department of Immunobiology
Term: Primary Appointment: with Tenure beginning July 1, 2013
Secondary Appointment: July 1, 2013 to June 30, 2018
School: Yale University School of Medicine and the Graduate School
Reason for Promotion: (to be written by department chair or section chief; inserted after candidate submits materials to Department)
Education:
A.B. Harvard College (History and Medicine) 1989
Ph.D. Yale University School of Medicine (Cell Biology) 1993
M.D. Yale University School of Medicine 1995
Career/Academic Appointments:
1995-96 Intern, Internal Medicine, Yale-New Haven Hospital, New Haven, CT
1996-98 Assistant and Senior Resident, Internal Medicine, Yale-New Haven Hospital, New Haven, CT
1998-01 Postdoctoral Fellow in Pathology, Duke University, Durham, N.C.
2001-02 Associate Research Scientist, Dept. of Pathology, Yale University School of Medicine, New Haven, CT
2002-08 Assistant Professor, Dept. of Pathology, Yale University School of Medicine, New Haven, CT
2008-present Associate Professor, Dept. of Pathology, Yale University School of Medicine, New Haven, CT
Administrative Positions:
2006-present Director, GI Pathology Laboratory, Yale University School of Medicine, New Haven, CT
2004-present Director, Core Facility for GI Pathology, Yale University School of Medicine, New Haven, CT
Board Certification:
American Board of Internal Medicine, Internal Medicine, 1998
American College of Pathology, Certification in Pathology, 2001
Professional Honors & Recognition (list from most recent to earliest):
International/National/Regional
2009: Interurban Club Sir William Osler Junior Investigator Award
2007: American College of Pathology, Pathology Investigator Award
2001: American College of Pathology, Senior Scholar Award
1993: Outstanding Medical Student Award
1993: Outstanding Medical Student Thesis Award
1989: Phi Beta Kappa, Harvard College
University
2006: The Junior Faculty Teaching Award, Yale University School of Medicine
Grant/Clinical Trials History: (list from most recent to earliest; total % effort on active grants and clinical trials must not exceed % effort toward research listed on CV Supplement)
Current Grants
Agency: NIH/NIAID SAMPLE R01 FORMAT
I.D.# R01 AI22222
Title: “Innate immunity in ulcerative colitis”
P.I.: Jane Doe, M.D.
Percent effort: 35%
Direct costs per year: $250,000
Total costs for project period: $2,043,750
Project period: 04/01/2009 – 03/31/2014
Agency: NIH/NIAID SAMPLE N01 FORMAT
ID#: R01 AI22222 Different PI
Title: “Innate immune responsiveness in the elderly GI tract”
P.I.: John Smith, M.D.
Role on Project: Co-investigator
Percent effort: 10%
Direct costs per year: $442,323
Total costs for project period: $7,097,957
Project period: 09/30/2010 – 09/29/2015
Current Clinical Trials
Agency: Astra Zeneca, Inc. SAMPLE CLINICAL TRIAL
I.D.# HIC# 080950034072 Site PI
Title: “A Phase III, Randomized, Parallel Group, Multi-Center Study in Renal Cancer Subjects to Compare the Efficacy of Compound 214 Monotherapy and the Combination of Compound 214 with Standard Therapy to the Efficacy of Standard Therapy”
Role: Yale Site Principal Investigator
Percent effort: 5%
Total costs for project period: $15,000/patient
Project period: 12/01/2011 – 5/31/2013
Agency: Veteran’s Administration Cooperative Studies Program
I.D.# CSP400 SAMPLE VA FUNDING
Title: VA evaluation of the utility of counseling for drug dependency in chronic disease
P.I.: Sara Kang, M.D.
Role on project: Investigator
Percent effort: 50%
Total costs for project period: $4,230,419
Project period: 10/01/2010 – 03/01/2013
Past Grants
Agency: Ulcerative Colitis Foundation Sample Foundation Grant
I.D.# Established Investigator Grant Format
Title: “Toll-like receptors in ulcerative colitis”
P.I.: Jane Doe, M.D.
Percent effort: 10%
Total costs for project period: $270,000
Project period: 07/01/2006 – 06/30/2008
Agency: NIH/NIAID SAMPLE PO1 FORMAT
I.D.# P01 AI30584 Different PI
Title: “Ulcerative colitis: pathogenesis and protection”
P.I.: John Smith, Ph.D.
Role on project: Core Director
Percent effort: 10%
Total costs for project period: $4,084,086
Project period: 09/30/2004 – 08/31/2007
Agency: NIH/NIAMS SAMPLE P30 FORMAT
I.D.# P30 22222 – Pilot Project Pilot Project
Title: “Epithelial resistance to gut pathogens”
P.I.: Jane Doe, M.D.
Percent effort: 5%
Total costs for project period: $20,000
Project period: 07/01/2002 – 06/30/2003
Agency: NIH/NIAMS SAMPLE K SERIES AWARD
I.D.# K08 AI22222 FORMAT
Title: “Pathology of ulcerative colitis”
P.I.: Jane Doe, M.D.
Percent effort: 50%
Total costs for project period: $577,500
Project period: 04/01/2001 – 03/31/2006
Agency: American College of Pathology SAMPLE FELLOWSHIP
I.D.# Postdoctoral Fellowship FORMAT
Title: “Gut pathology”
P.I.: Jane Doe, M.D.
Percent effort: 90%
Total costs for project period: $37,000
Project period: 07/01/1999 – 06/30/2001
Past Clinical Trials
Agency: CSL Behring
I.D.# Protocol # 07-06-01
Title: “Evaluation of the efficacy and safety of Compound 24559 in pediatric subjects with newly diagnosed inflammatory bowel disease”
P.I.: Jane Doe, MD, PhD
Percent effort: 10%
Total costs for project period: $210,000
Project period: 10/01/2007 – 09/30/2009
Invited Speaking Engagements, Presentations, Symposia & Workshops Not Affiliated With Yale: (list from most recent to earliest)
International/National
2011: Xth International Conference on Ulcerative Colitis, Vienna, Austria: "Innate immune defenses in ulcerative colitis”
2009: Gordon Research Conference on Inflammatory Bowel Disease, Woods Hole, MA, Discussion Leader and Speaker, Plenary Session on Innate Immunity, “Innate immunity in ulcerative colitis”
2005: American College of Pathology, Winter Symposium, Snowmass, CO, “Ulcerative colitis”
Regional
2005: University of Connecticut Pathology Seminar: “Innate immunity in ulcerative colitis”
Peer-Reviewed Presentations & Symposia Given at Meetings Not Affiliated With Yale: (list from most recent to earliest)
International/National
2006: Gordon Research Conference on Inflammatory Bowel Disease, Woods Hole, MA, "IL-22 produced by CD4+T cells protects mice from inflammatory bowel disease."
2005: Annual Meeting, American College of Gastroenterology, San Francisco, CA, Mini-symposium on inflammatory bowel disease: NOD-like receptors in inflammatory bowel disease."
2004: Annual Meeting, American College of Gastroenterology, Boston, MA, Concurrent session on inflammatory bowel disease: "IL-22 producing NK cells protect mice from inflammatory bowel disease."
Regional
2003: New England Immunology Conference, Woods Hole, MA. "Th17 cells are increased in a murine model of inflammatory bowel disease."
Professional Service
Peer Review Groups/Grant Study Sections: (list from most recent to earliest)
2008-present Member, Inflammatory Bowel Disease Study Section, NIH/NIAID
2004-present Member, Scientific Advisory Committee, American College of Pathology
2004-05 Ad hoc Member, Inflammatory Bowel Disease Study Section, NIH/NIAID
2004 Member, Special Emphasis Panel for ZRG22222, Inflammatory Bowel Disease NIH/NIAID
2004 NIH: Special Review Group ZRG22222, Immunology of Ulcerative Colitis Review, NIH/NIAID
Journal Service:
Editor/Associate Editor
2005-present Editor, Journal of Immunology
Reviewer
2002-present Reviewer for Nature, Science, JAMA, Journal of Experimental Medicine, The Journal of Immunology, Journal of Infectious Diseases
Professional Service for Professional Organizations: (list from most recent to earliest)
Pathology Foundation
2009-present Member, Medical & Scientific Council, National Pathology Foundation
2009-present Liaison from PF Medical & Scientific Council to the American College of Pathology Committee on Research
2008-09 Member, Committee on Bylaws, Pathology Foundation New England Chapter
2007-present Member, Board of Directions, Pathology Foundation New England Chapter
2005-present Chair, Medical & Scientific Committee, Pathology Foundation, New England Chapter
American College of Pathology
2009-present Member, Scientific Advisory Council, Research & Education Foundation
2006-present Member, Board of Directors, Research & Education Foundation
2006-07 Member, Awards & Grants Committee
2004-05 Chair, Subcommittee on Recommended Changes to Pathology Training Program
Requirements, Committee on Training & Workforce Issues
2001-04 Member, Committee on Training & Workforce Issues
Meeting Planning/Participation
2005 Chair, Immunology II Session, Xth International Conference on Inflammatory Bowel Disease 2004 Chair, Minisymposium, Inflammatory Bowel Disease, International Meeting, American College of Pathology
2002-present American College of Pathology, Abstract Selection Committee: Inflammatory Bowel Disease
2002 Member, Subcommittee on Immunology, IXth International Conference on Inflammatory Bowel Disease
Yale University Service: (list from most recent to earliest)
University Committees
2004-2007 Member, Radiation Safety Committee, Yale University
Medical School Committees
2005-present Member, Committee on Status of Women in Medicine, School of Medicine
2003-2005 Member, Search Committee for Chair of Pathology, Veterans Administration Healthcare Systems, West Haven, CT
2005 Reviewer, Pathology Center Pilot Project applications
Departmental Committees
2004-present Member, Appointment & Promotions Committee, Dept. of Pathology, School of Medicine
Hospital Boards & Committees
2003-present Member, Autopsy Committee, Yale-New Haven Hospital
2001-2002 Member, Autopsy Committee, Veterans Administration Healthcare System
Public Service:
2010 Featured Expert and Consultant, Discovery Health/BBC Production, Immune-mediated Gastrointestinal Disease, Discovery Health Channel
Bibliography: (list from earliest to most recent and number consecutively)
Peer-Reviewed Original Research
1. Doe, J., and L.S. Frank.. Title. Journal of Clinical Investigation 1980, 65:1372-1381.
2. Doe, J., L.S. Frank, and L. Liu. Title. Nature Medicine 2006, 74:2154-2160.
Chapters, Books, and Reviews
3. Doe, J. Inflammatory Bowel Disease: Ulcerative colitis. In Gastrointestinal Immunology, 10th edition, ed. T.G. HIiminez, D.P. Smith, and A.I.Eagle, McGraw-Hill Co., New York, NY, 2001, pp. 688-697.
4. Doe, J. Ulcerative colitis. In Current Diagnosis & Treatment in Gastroenterology, 2nd edition, eds. J. R. Schmidt, D..M. Khan and P.S. Zhang, McGraw-Hill Co., New York, NY, 2005, pp. 500-525.
5. Textbook of GI Pathology, 5th edition, ed. J. Doe and T.G. Himinez, Elsevier, Amsterdam, Netherlands, 2003.
Peer-Reviewed Educational Materials
6. Doe, J. Peer Observation and Feedback, MedEdPORTAL 2011. Available from www.mededportal.org/publication/#
Invited Editorials and Commentaries
7. Doe, J. Ulcerative colitis—more answers, more questions. New England Journal of Medicine, 2009, 390:1991-1993.
Practice Guidelines, Standards and Consensus Statements
8. Doe, J., L. Liu, and I.S.. Frank. Clinical Guidelines on the Evaluation and Treatment of Inflammatory Bowel Disease. McGraw-Hill Co., New York, NY, 2005.
Case Reports, Technical Notes, Letters
9. Doe, J., L. Liu, and I.S. Frank. Letter (reply). Digestive Diseases. 2003, 187:1676.
Scholarship In Press
10. Doe, J., and I.S. Frank. Title. Journal of Clinical Investigation. doi:10.1189/JCI98448
11. Doe, J., F. Khan, and P.S. Zhan. Title. Journal of Immunology, in press.
1
Revised by Office for Faculty Affairs 05-03-2013